Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (51-60 of 326) with videos related to

Pageof 33
Sort By:
Nature Reviews. Gastroenterology & Hepatology|March 7, 2025
Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatmentChristopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2015
A "systems medicine" approach to the study of non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Elisabetta Bugianesi, et al.
Nature Reviews. Gastroenterology & Hepatology|February 17, 2025
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatmentChristopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Clinics and Research in Hepatology and Gastroenterology|January 14, 2021
Association between gut permeability and insulin resistance: Any role for zonulin in patients with non-alcoholic fatty liver disease?Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, et al.
Expert Review of Gastroenterology & Hepatology|September 8, 2021
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature reviewJörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2010
Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver diseaseGiampaolo Bianchi, Elisabetta Bugianesi, Jan Frystyk, et al.
Nature Reviews. Gastroenterology & Hepatology|August 27, 2025
Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatmentChristopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
BMJ (Clinical Research Ed.)|October 9, 2023
Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for interventionManuel Romero-Gómez, Shira Zelber-Sagi, Franz Martín, et al.
BMC Gastroenterology|April 18, 2019
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United StatesPegah Golabi, James Paik, Rashmi Reddy, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|July 5, 2022
Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicineNuria Perez-Diaz-Del-Campo, Diego Martínez-Urbistondo, Elisabetta Bugianesi, et al.
Pageof 33

Showing results (51-60 of 326) with videos related to

Sort By:
Pageof 33
Nature Reviews. Gastroenterology & Hepatology|March 7, 2025
Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatmentChristopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2015
A "systems medicine" approach to the study of non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Elisabetta Bugianesi, et al.
Nature Reviews. Gastroenterology & Hepatology|February 17, 2025
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatmentChristopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Clinics and Research in Hepatology and Gastroenterology|January 14, 2021
Association between gut permeability and insulin resistance: Any role for zonulin in patients with non-alcoholic fatty liver disease?Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, et al.
Expert Review of Gastroenterology & Hepatology|September 8, 2021
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature reviewJörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2010
Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver diseaseGiampaolo Bianchi, Elisabetta Bugianesi, Jan Frystyk, et al.
Nature Reviews. Gastroenterology & Hepatology|August 27, 2025
Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatmentChristopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
BMJ (Clinical Research Ed.)|October 9, 2023
Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for interventionManuel Romero-Gómez, Shira Zelber-Sagi, Franz Martín, et al.
BMC Gastroenterology|April 18, 2019
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United StatesPegah Golabi, James Paik, Rashmi Reddy, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|July 5, 2022
Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicineNuria Perez-Diaz-Del-Campo, Diego Martínez-Urbistondo, Elisabetta Bugianesi, et al.
Pageof 33